| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |